![]() ![]() 10 Vertebral augmentation provides a significant mortality benefit over nonsurgical management with a low number needed to treat (NNT). 11 Under-diagnosis and under-treatment may exacerbate morbidity and mortality. 10 Medicare claims data shows a 85% 10-year mortality following a VCF diagnosis. ![]() They may cause significant acute and chronic pain, leading to complications of impaired mobility (comparable to a hip fracture, pneumonia, loss of bone and muscle mass, incidental falls, deep venous thrombosis, depression, and isolation). VCFs constitute one-quarter of osteoporotic fractures, 6 often at the midthoracic (T7-T8) and thoracolumbar junction (T12-L1). Its primary impact, fractures (also called fragility or low-trauma fractures), occurs secondary to normal activity (e.g., bending, coughing, lifting, fall from a standing height), and eventually occurs in 50% of women and 20% of men. Osteoporosis (and low bone mass) affects 50% of people over 50 years of age, or over 50 million people in the United States. Vertebral augmentation and kyphoplasty for VCFs with intractable spinal pain not relieved with medical therapy will be covered for osteolytic vertebral metastatic disease or myeloma involving a vertebral body.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |